156 related articles for article (PubMed ID: 15591773)
1. Mechanisms involved in the antiplatelet activity of ketamine in human platelets.
Chang Y; Chen TL; Wu GJ; Hsiao G; Shen MY; Lin KH; Chou DS; Lin CH; Sheu JR
J Biomed Sci; 2004; 11(6):764-72. PubMed ID: 15591773
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms involved in the antiplatelet activity of midazolam in human platelets.
Sheu JR; Hsiao G; Luk HN; Chen YW; Chen TL; Lee LW; Lin CH; Chou DS
Anesthesiology; 2002 Mar; 96(3):651-8. PubMed ID: 11873041
[TBL] [Abstract][Full Text] [Related]
3. alpha-Naphthoflavone, a potent antiplatelet flavonoid, is mediated through inhibition of phospholipase C activity and stimulation of cyclic GMP formation.
Hsiao G; Chang CY; Shen MY; Chou DS; Tzeng SH; Chen TF; Sheu JR
J Agric Food Chem; 2005 Jun; 53(13):5179-86. PubMed ID: 15969494
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms involved in the antiplatelet activity of Staphylococcus aureus lipoteichoic acid in human platelets.
Sheu JR; Lee CR; Lin CH; Hsiao G; Ko WC; Chen YC; Yen MH
Thromb Haemost; 2000 May; 83(5):777-84. PubMed ID: 10823277
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory mechanisms of metallothionein on platelet aggregation in in vitro and platelet plug formation in in vivo experiments.
Sheu JR; Hsiao G; Shen MY; Wang Y; Lin KH; Lin CH; Chou DS
Exp Biol Med (Maywood); 2003 Dec; 228(11):1321-8. PubMed ID: 14681547
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms involved in the antiplatelet activity of Escherichia coli lipopolysaccharide in human platelets.
Sheu JR; Hung WC; Kan YC; Lee YM; Yen MH
Br J Haematol; 1998 Oct; 103(1):29-38. PubMed ID: 9792285
[TBL] [Abstract][Full Text] [Related]
7. Expression of matrix metalloproteinase-9 in human platelets: regulation of platelet activation in in vitro and in vivo studies.
Sheu JR; Fong TH; Liu CM; Shen MY; Chen TL; Chang Y; Lu MS; Hsiao G
Br J Pharmacol; 2004 Sep; 143(1):193-201. PubMed ID: 15289295
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms involved in the antiplatelet activity of magnesium in human platelets.
Sheu JR; Hsiao G; Shen MY; Fong TH; Chen YW; Lin CH; Chou DS
Br J Haematol; 2002 Dec; 119(4):1033-41. PubMed ID: 12472585
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effects of lycopene on in vitro platelet activation and in vivo prevention of thrombus formation.
Hsiao G; Wang Y; Tzu NH; Fong TH; Shen MY; Lin KH; Chou DS; Sheu JR
J Lab Clin Med; 2005 Oct; 146(4):216-26. PubMed ID: 16194683
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms involved in the antiplatelet activity of rutin, a glycoside of the flavonol quercetin, in human platelets.
Sheu JR; Hsiao G; Chou PH; Shen MY; Chou DS
J Agric Food Chem; 2004 Jul; 52(14):4414-8. PubMed ID: 15237945
[TBL] [Abstract][Full Text] [Related]
11. C-phycocyanin, a very potent and novel platelet aggregation inhibitor from Spirulina platensis.
Hsiao G; Chou PH; Shen MY; Chou DS; Lin CH; Sheu JR
J Agric Food Chem; 2005 Oct; 53(20):7734-40. PubMed ID: 16190625
[TBL] [Abstract][Full Text] [Related]
12. Antiplatelet activity of caffeic acid phenethyl ester is mediated through a cyclic GMP-dependent pathway in human platelets.
Chen TG; Lee JJ; Lin KH; Shen CH; Chou DS; Sheu JR
Chin J Physiol; 2007 Jun; 50(3):121-6. PubMed ID: 17867432
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory mechanisms of kinetin, a plant growth-promoting hormone, in platelet aggregation.
Sheu JR; Hsiao G; Shen MY; Chou CY; Lin CH; Chen TF; Chou DS
Platelets; 2003 May; 14(3):189-96. PubMed ID: 12850843
[TBL] [Abstract][Full Text] [Related]
14. Involvement of the antiplatelet activity of magnesium sulfate in suppression of protein kinase C and the Na+/H+ exchanger.
Hsiao G; Shen MY; Chou DS; Lin CH; Chen TF; Sheu JR
J Biomed Sci; 2004; 11(1):19-26. PubMed ID: 14730206
[TBL] [Abstract][Full Text] [Related]
15. Ketamine suppresses platelet aggregation possibly by suppressed inositol triphosphate formation and subsequent suppression of cytosolic calcium increase.
Nakagawa T; Hirakata H; Sato M; Nakamura K; Hatano Y; Nakamura T; Fukuda K
Anesthesiology; 2002 May; 96(5):1147-52. PubMed ID: 11981155
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory mechanisms of low concentrations of oxidized low-density lipoprotein on platelet aggregation.
Chou DS; Chan CH; Hsiao G; Shen MY; Tsai YJ; Chen TF; Sheu JR
J Biomed Sci; 2006 May; 13(3):333-43. PubMed ID: 16283430
[TBL] [Abstract][Full Text] [Related]
17. Thromboxane A2-mediated shape change: independent of Gq-phospholipase C--Ca2+ pathway in rabbit platelets.
Ohkubo S; Nakahata N; Ohizumi Y
Br J Pharmacol; 1996 Mar; 117(6):1095-104. PubMed ID: 8882602
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effect of 8-bromo cyclic GMP on an extracellular Ca2+-dependent arachidonic acid liberation in collagen-stimulated rabbit platelets.
Matsuoka I; Nakahata N; Nakanishi H
Biochem Pharmacol; 1989 Jun; 38(11):1841-7. PubMed ID: 2544181
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms involved in the antiplatelet activity of tetramethylpyrazine in human platelets.
Sheu JR; Kan YC; Hung WC; Ko WC; Yen MH
Thromb Res; 1997 Nov; 88(3):259-70. PubMed ID: 9526946
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of antiplatelet and antithrombotic activity of midazolam in in vitro and in vivo studies.
Hsiao G; Shen MY; Chou DS; Chang Y; Lee LW; Lin CH; Sheu JR
Eur J Pharmacol; 2004 Mar; 487(1-3):159-66. PubMed ID: 15033388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]